Recent advances in polymeric core-shell nanocarriers for targeted delivery of chemotherapeutic drugs

Abstract

The treatment effect of chemotherapeutics is often impeded by nonspecific biodistribution and limited biocompatibility. Polymeric core-shell nanocarriers (PCS NCs) composed of a polymer core and at least one shell have been widely applied for cancer therapy and have shown great potential in selectively delivering chemotherapeutic drugs to tumor sites. These PCS NCs can effectively ameliorate the delivery efficiency and therapeutic index of anticarcinogens by prolonging drug residence in the bloodstream, enhancing tumor tissue drug penetration, facilitating cellular drug uptake, controlling the spatiotemporal release of payloads, or codelivering two or more bioactive agents. This review summarizes recently published literature on using PCS NCs to transport chemotherapeutic drugs with poor aqueous solubility and discusses their design principles, structural features, functional properties, and potential limitations.

Keywords: Biological barriers; Camptothecin (PubChem CID: 24360); Chemotherapeutics; Chitosan (PubChem CID: 71853); Delivery strategy; Dextran (PubChem CID: 105075); Doxorubicin (PubChem CID: 31703); Folic acid (PubChem CID: 135398658); Hyaluronic acid (PubChem CID: 6852395); Paclitaxel (PubChem CID: 36314); Polyamidoamine (PubChem CID: 161547); Polyethylene glycol (PubChem CID: 174); Polylactic acid (PubChem CID: 612); Polymeric core–shell nanocarriers; Tumor targeting.